Regeneron to create 60 new jobs in Limerick facility

The company has also announced that it has reached a milestone of 1,000 employees at its facility in Limerick.

Biopharma giant Regeneron has announced plans to hire 60 additional staff to its plant in Limerick.

The company, which has an industrial operations and product supply (IOPS) facility at the Raheen Industrial Estate, has also reached the milestone of employing 1,000 people at its facility.

The biotechnology company acquired the former Dell computer facility in Limerick and achieved planning in 2014 for its first IOPS site outside of the United States.

Investing in growth

Headquartered in New York, Regeneron has invested almost €1 billion over the past six years to build the largest biologics manufacturing facility in Ireland.

“It feels surreal to now have over 1,000 of the most talented people in the industry working at our Raheen site,” said Daniel Van Plew, executive vice president and general manager.

“At the time we decided to set up shop in Limerick, I didn’t fully appreciate the depth of the Irish talent pool or how welcoming the community would be.

“It is a privilege to continue to work and grow in Limerick, and to be surrounded by so many hardworking and innovative people.”

Niall O’Leary, vice president and site head, IOPS added; “Employees at Regeneron work with a start-up mentality, have a strong team culture, and are passionate about the work we do.”

“That has been Regeneron’s mindset for decades and we’ve brought the same attitude across the Atlantic. Since we hired our first employee in Ireland six years ago, to the 1000th employee today, we have continuously looked for people that fit our culture and this has served us very well. Our team is world-class.”

Covid treatment

Earlier this month Regeneron said it planned to increase the number of medicines manufactured at its Limerick facility in order to ramp up production of their Covid-19 drug treatment in the US.

The company is advancing its antibody “cocktail” treatment called REGN-COV2 designed to prevent and treat the SARS-CoV-2 virus.

The company said the treatment for Covid-19 could be available as soon as this autumn with plans to scale up its manufacturing to produce 200,000 doses per month by the end of summer.

For the last four years, Regeneron Ireland has been recognised as one of the best places to work in Ireland.

By Stephen Larkin

Published: 27 May, 2020